Expression modes and clinical manifestations of latent membrane protein 1, Ki-67, cyclin-B1, and epidermal growth factor receptor in nonendemic nasopharyngeal carcinoma

Head and Neck

Volumn 31, Issue 4, 2009, Pages 482-492

  Taheri Kadkhoda, Zahra ^a   Magnusson, Bengt ^a   Svensson, Marie ^a   Mercke, Claes ^a   Björk Eriksson, Thomas ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cyclin B1; EGFR; Ki 67; LMP1; Nasopharyngeal carcinoma

Indexed keywords

CISPLATIN; CYCLIN B1; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; KI 67 ANTIGEN; LATENT MEMBRANE PROTEIN 1;

ADOLESCENT; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHILD; CYCLIN B; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL; VIRAL MATRIX PROTEINS; YOUNG ADULT;

EID: 65649141651     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21002     Document Type: Article

References (37)

1. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002;53:12-22. (Pubitemid 34632602)
2. Kieff E. Epstein-Barr virus-increasing evidence of a link to carcinoma. N Engl J Med 1995;333:724-726.
3. Li HP, Chang YS. Epstein-Barr virus latent membrane protein 1: structure and functions. J Biomed Sci 2003;10:490-504. (Pubitemid 37025959)
4. Zheng X, Hu L, Chen F, Christensson B. Expression of Ki67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma. Eur J Cancer B Oral Oncol 1994;30B:290-295.
5. Miller WE, Earp HS, Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol 1995;69:4390-4398.
6. AkimotoT,HunterNR,BuchmillerL,MasonK,AngKK,MilasL. Inverserelationshipbetweenepidermalgrowthfactorreceptorexpressionand radiocurabilityofmurinecarcinomas.ClinCancerRes1999;5:2884-2890. (Pubitemid29493967)
7. Ang KK, Berkey BA, Tu X, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002;62:7350-7356.
8. Ma BB, Poon TC, To KF, et al. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma - a prospective study. Head Neck 2003;25:864-872. (Pubitemid 37139899)
9. Chua DT, Nicholls JM, Sham JS, Au GK. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2004;59:11-20. (Pubitemid 38501502)
10. Leong JL, Loh KS, Putti TC, Goh BC, Tan LK. Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx. Laryngoscope 2004;114:153-157. (Pubitemid 38141085)
11. Fang FM, Li CF, Chien CY, Rau KM, Huang HY. Immunohistochemical expression of epidermal growth factor receptor and cyclooxygenase-2 in pediatric nasopharyngeal carcinomas: no significant correlations with clinicopathological variables and treatment outcomes. Int J Pediatr Otorhinolaryngol 2007;71:447-455.
12. HassanKA,El-NaggarAK,SoriaJC,LiuD,HongWK,MaoL. ClinicalsignificanceofcyclinB1proteinexpressioninsquamouscellcarcinomaof thetongue.ClinCancerRes2001;7:2458-2462.(Pubitemid32751649)
13. Hassan KA, Ang KK, El-Naggar AK, et al. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res 2002;62:6414-6417.
14. Murakami H, Furihata M, Ohtsuki Y, Ogoshi S. Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Arch 1999;434:153-158. (Pubitemid 29184993)
15. KushnerJ,BradleyG,YoungB,JordanRC. AberrantexpressionofcyclinAandcyclinB1proteinsinoralcarcinoma. JOralPatholMed1999;28:77-81.(Pubitemid29064508)
16. Henderson S, Rowe M, Gregory C, et al. Induction of bcl- 2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991;65:1107-1115.
17. MillerWE,MosialosG,KieffE,Raab-TraubN.Epstein- BarrvirusLMP1inductionoftheepidermalgrowthfactorreceptorismediatedthrough aTRAFsignalingpathwaydistinctfromNF-kappaBactivation.JVirol1997;71:586-594. (Pubitemid26412329)
18. HorikawaT,SheenTS,TakeshitaH,SatoH,FurukawaM,YoshizakiT. Inductionofc-Metproto-oncogenebyEpstein-Barrviruslatentmembraneprotein- 1andthecorrelationwithcervicallymphnodemetastasisofnasopharyngealcarcinoma. AmJPathol2001;159:27-33.(Pubitemid33704188)
19. Liu B, Chen XY. [Effect of EB virus latent membrane protein 1 on mitosis control of nasopharyngeal carcinoma cell line CNE1]. Ai Zheng 2004;23:512-516.
20. Deng L, Yang J, Zhao XR, et al. Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP- 1. Cell Res 2003;13:187-194.
21. Horikawa T, Yoshizaki T, Sheen TS, Lee SY, Furukawa M. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 2000;89:715-723. (Pubitemid 30658568)
22. Sarac S, Akyol MU, Kanbur B, et al. Bcl-2 and LMP1 expression in nasopharyngeal carcinomas. Am J Otolaryngol 2001;22:377-382.
23. D'Addario M, Chauvin P. Ethnic differences in the expression of Epstein-Barr virus latent membrane protein- 1 mutations in nasopharyngeal carcinoma. Mutat Res 2000;457:69-78.
24. Gondhowiardjo S. Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) and tumor proliferation rate as predictive factors of nasopharyngeal cancer (NPC) radiation response. Gan To Kagaku Ryoho 2000;27 (Suppl 2):323-331.
25. Khabir A, Karray H, Rodriguez S, et al. EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas. Virol J 2005;2:39.
26. Duraiswamy J, Sherritt M, Thomson S, et al. Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma. Blood 2003;101:3150-3156.
27. Roland NJ, Caslin AW, Bowie GL, Jones AS. Has the cellular proliferation marker Ki67 any clinical relevance in squamous cell carcinoma of the head and neck? Clin Otolaryngol Allied Sci 1994;19:13-18.
28. Masuda M, Shinokuma A, Hirakawa N, Nakashima T, Komiyama S. Expression of bcl-2-, p53, and Ki-67 and outcome of patients with primary nasopharyngeal carcinomas following DNA-damaging treatment. Head Neck 1998;20:640-644.
29. Myoung H, Kim MJ, Lee JH, Ok YJ, Paeng JY, Yun PY. Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients. Int J Oral Maxillofac Surg 2006;35:1005-1010. (Pubitemid 44615441)
30. Roychowdhury DF, Tseng A Jr, Fu KK, Weinburg V, Weidner N. New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression. Cancer 1996;77:1419-1426.
31. Kallakury BV, Sheehan CE, Rhee SJ, et al. The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2. Cancer 1999;85:1569-1576.
32. Soria JC, Jang SJ, Khuri FR, et al. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 2000;60:4000-4004.
33. Yasuda M, Takesue F, Inutsuka S, Honda M, Nozoe T, Korenaga D. Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological study. J Cancer Res Clin Oncol 2002;128:412-416.
34. Shen M, Feng Y, Gao C, et al. Detection of cyclin b1 expression in g(1)-phase cancer cell lines and cancer tissues by postsorting Western blot analysis. Cancer Res 2004;64:1607-1610.
35. Santini J, Formento JL, Francoual M, et al. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 1991;13:132-139.
36. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-578.
37. Sheen TS, Huang YT, Chang YL, et al. Epstein-Barr virus- encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma. Jpn J Cancer Res 1999;90:1285-1292.